Medivolve Announces Board Changes
07 November 2023 - 1:30PM
Medivolve Inc. (“
Medivolve” or the
“
Company”) (NEO: MEDV; OTC: MEDVF; FRA:4NC)
announces today that Dr. Beverley Richardson has resigned from its
board of directors, effective immediately. The Company intends to
announce the appointment of Dr. Richardson’s replacement in the
near future. Management and the board would like to thank Dr.
Richardson for her services and extensive contributions to the
Company and wish her well in her future endeavours.
About Medivolve Inc.
Medivolve is a Canadian healthcare
technology company headquartered in Toronto, Canada. The Company’s
mission is to improve health and lives by delivering world-class
diagnostic solutions—starting with COVID-19—as well as to enable
faster and better care to patients through innovative technology.
Medivolve, through its subsidiaries, operates retail patient-care
locations in California.
For investing inquiries, please
contact: David Preiner, CEO, info@medivolve.ca,
702-990-3737.
Cautionary Note Regarding
Forward-looking Information
This press release contains "forward-looking
information" within the meaning of applicable Canadian securities
legislation. Forward-looking information includes, but is not
limited to, statements with respect to the appointment of
directors. Generally, forward-looking information can be identified
by the use of forward-looking terminology such as "plans",
"expects" or "does not expect", "is expected", "budget",
"scheduled", "estimates", "forecasts", "intends", "anticipates" or
"does not anticipate", or "believes", or variations of such words
and phrases or state that certain actions, events or results "may",
"could", "would", "might" or "will be taken", "occur" or "be
achieved". Forward-looking information is subject to known and
unknown risks, uncertainties and other factors that may cause the
actual results, level of activity, performance or achievements of
the Company, as the case may be, to be materially different from
those expressed or implied by such forward-looking information,
including (but not limited to) the Company’s ability to attract and
retain qualified personnel. Although the Company has attempted to
identify important factors that could cause actual results to
differ materially from those contained in forward-looking
information, there may be other factors that cause results not to
be as anticipated, estimated or intended. There can be no assurance
that such information will prove to be accurate, as actual results
and future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue
reliance on forward-looking information. The Company does not
undertake to update any forward-looking information, except in
accordance with applicable securities laws.
Medivolve (NEO:MEDV)
Historical Stock Chart
From Oct 2024 to Nov 2024
Medivolve (NEO:MEDV)
Historical Stock Chart
From Nov 2023 to Nov 2024